• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    LightWave Acquisition Corp. Announces Closing of $215,625,000 Initial Public Offering, Including Full Exercise of Underwriters' Over-Allotment Option

    6/26/25 3:07:28 PM ET
    $LWAC
    Get the next $LWAC alert in real time by email

    Dallas, TX, June 26, 2025 (GLOBE NEWSWIRE) -- LightWave Acquisition Corp. (the "Company"), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company, today announced the closing of its initial public offering of 21,562,500 units at an offering price of $10.00 per unit. This includes the exercise in full by the underwriters of their over-allotment option to purchase up to an additional 2,812,500 units. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant will entitle the holder thereof to purchase one Class A ordinary share at $11.50 per share. The units are listed on the Nasdaq Global Market ("Nasdaq") and trade under the ticker symbol "LWACU". No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Once the securities comprising the units begin separate trading, the Class A ordinary shares and the warrants are expected to be traded on Nasdaq under the symbols "LWAC" and "LWACW," respectively.

    The Company intends to use the net proceeds from the offering and the simultaneous private placement of units to pursue and consummate  a business combination with one or more businesses.

    BTIG, LLC is acting as sole book-running manager for the offering. Roberts and Ryan, Inc. is acting as co-manager.

    The offering was made only by means of a prospectus. Copies of the prospectus may be obtained from: BTIG, LLC, 65 East 55th Street New York, New York 10022, Attn: Syndicate Department, or by email at [email protected], or by accessing the website of the Securities and Exchange Commission ("SEC") at www.sec.gov.

    A registration statement relating to the securities has been filed with, and declared effective by, the SEC. This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

    About LightWave Acquisition Corp.

    LightWave Acquisition Corp. is a blank check company, also commonly referred to as a special purpose acquisition company, or SPAC, formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. While the Company may pursue a business combination in any sector, the Company will primarily focus on target businesses in the technology industry. The Company's management team is led by Robert M. Bennett, its Chief Executive Officer and Chairman of the Board of Directors (the "Board"), and William W. Bunker, its Chief Financial Officer and Vice Chairman of the Board. In addition, the Board includes Robert Hochberg, Charlotte S. Blechman, and Allen C. Dickason.

    Forward-Looking Statements

    This press release contains statements that constitute "forward-looking statements," including with respect to the Company's initial public offering ("IPO"), the anticipated use of the net proceeds thereof and the Company's search for an initial business combination. No assurance can be given that the net proceeds of the offering will be used as indicated. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company's registration statement and prospectus for the IPO filed with the SEC. Copies are available on the SEC's website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

    Contacts:

    Robert Bennett

    Chief Executive Officer

    [email protected]



    Get the next $LWAC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $LWAC

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $LWAC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    LightWave Acquisition Corp. Announces Closing of $215,625,000 Initial Public Offering, Including Full Exercise of Underwriters' Over-Allotment Option

    Dallas, TX, June 26, 2025 (GLOBE NEWSWIRE) -- LightWave Acquisition Corp. (the "Company"), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company, today announced the closing of its initial public offering of 21,562,500 units at an offering price of $10.00 per unit. This includes the exercise in full by the underwriters of their over-allotment option to purchase up to an additional 2,812,500 units. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant will entitle the holder thereof to purchase one Class A ordinary share at $11.50 per share. The units are listed on the Nasdaq Global Market ("N

    6/26/25 3:07:28 PM ET
    $LWAC

    LightWave Acquisition Corp. Announces Pricing of $187,500,000 Initial Public Offering

    Dallas, TX, June 24, 2025 (GLOBE NEWSWIRE) -- LightWave Acquisition Corp. (the "Company"), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company, today announced the pricing of its initial public offering of 18,750,000 units at an offering price of $10.00 per unit, with each unit consisting of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant, which becomes exercisable 30 days after the completion of the Company's initial business combination, will entitle the holder thereof to purchase one Class A ordinary share at $11.50 per share. The units are expected to trade on the Nasdaq Stock Market LLC ("Nasdaq") und

    6/24/25 6:44:57 PM ET
    $LWAC

    Locust Walk Acquisition Corp.'s Stockholders Approve Business Combination with eFFECTOR Therapeutics to Create Next-Generation Oncology Company Developing New Class of Cancer Therapies

    SAN DIEGO, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Locust Walk Acquisition Corp. (NASDAQ:LWAC) ("LWAC" or the "Company"), a special purpose acquisition company, announced today that the Company's stockholders have approved all proposals related to the previously announced business combination (the "Business Combination") with eFFECTOR Therapeutics, Inc. ("eFFECTOR") at a special meeting of stockholders held on August 24, 2021. Approximately 93.2% of the votes cast at the meeting on the Business Combination proposal, representing approximately 71.7% of LWAC's outstanding shares, voted to approve the Business Combination. LWAC stockholders also voted overwhelmingly to approve the other proposals

    8/24/21 4:47:39 PM ET
    $LWAC

    $LWAC
    SEC Filings

    View All

    $LWAC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $LWAC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 10-Q filed by LightWave Acquisition Corp.

    10-Q - LightWave Acquisition Corp. (0002061379) (Filer)

    11/14/25 2:57:11 PM ET
    $LWAC

    Amendment: SEC Form SCHEDULE 13G/A filed by LightWave Acquisition Corp.

    SCHEDULE 13G/A - LightWave Acquisition Corp. (0002061379) (Subject)

    11/13/25 8:08:20 AM ET
    $LWAC

    SEC Form SCHEDULE 13G filed by LightWave Acquisition Corp.

    SCHEDULE 13G - LightWave Acquisition Corp. (0002061379) (Subject)

    11/12/25 4:41:07 PM ET
    $LWAC

    Large owner Lightwave Founders Llc bought $6,062,500 worth of Class A ordinary shares (606,250 units at $10.00) (SEC Form 4)

    4 - LightWave Acquisition Corp. (0002061379) (Issuer)

    7/9/25 4:50:58 PM ET
    $LWAC

    SEC Form 3 filed by new insider Dickason Allen Charles

    3 - LightWave Acquisition Corp. (0002061379) (Issuer)

    7/9/25 4:54:59 PM ET
    $LWAC

    Large owner Lightwave Founders Llc bought $6,062,500 worth of Class A ordinary shares (606,250 units at $10.00) (SEC Form 4)

    4 - LightWave Acquisition Corp. (0002061379) (Issuer)

    7/9/25 4:50:58 PM ET
    $LWAC

    SEC Form 3 filed by new insider Lightwave Founders Llc

    3 - LightWave Acquisition Corp. (0002061379) (Issuer)

    6/24/25 9:27:54 PM ET
    $LWAC

    $LWAC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by Locust Walk Acquisition Corp.

    SC 13D - eFFECTOR Therapeutics, Inc. (0001828522) (Subject)

    9/13/21 6:23:36 AM ET
    $LWAC

    SEC Form SC 13D filed by Locust Walk Acquisition Corp.

    SC 13D - eFFECTOR Therapeutics, Inc. (0001828522) (Subject)

    9/7/21 5:12:00 PM ET
    $LWAC

    SEC Form SC 13D filed by Locust Walk Acquisition Corp.

    SC 13D - eFFECTOR Therapeutics, Inc. (0001828522) (Subject)

    9/3/21 4:00:25 PM ET
    $LWAC